Patents/Assignees

Aldeyra Therapeutics, Inc.

17 patents in portfolio

US12616699utility2026
Ophthalmic Formulations of Methotrexate
0 cites
US12240816utility2025
Deuterated Compounds and Uses Thereof
0 cites
US12128013utility2024
Toxic Aldehyde Related Diseases and Treatment
0 cites
US12097188utility2024
Compositions and Methods for the Treatment of Macular Degeneration
0 cites
US12098132utility2024
Process for Preparation of Aldehyde Scavenger and Intermediates
0 cites
US12064516utility2024
Pharmaceutical Formulations and Uses Thereof
0 cites
US12029735utility2024
Polymorphic Compounds and Uses Thereof
0 cites
US12005061utility2024
Ophthalmic Formulations of Methotrexate
0 cites
US12005060utility2024
Ophthalmic Formulations of Methotrexate
0 cites
US12006298utility2024
Polymorphic Compounds and Uses Thereof
0 cites
US11911385utility2024
Methotrexate Treatment Methods
0 cites
US11845722utility2023
Deuterated Compounds and Uses Thereof
0 cites
US11786518utility2023
Ophthalmic Formulations and Uses Thereof
0 cites
US11771664utility2023
Toxic Aldehyde Related Diseases and Treatment
0 cites
US11724987utility2023
Compositions and Methods of Treating Retinal Disease
0 cites
US11701331utility2023
Toxic Aldehyde Related Diseases and Treatment
0 cites
US11583529utility2023
Treatment of Inflammatory Disorders
0 cites